Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0LI2E
|
|||
Drug Name |
Tetra-hydro-imidazo[1,5-d][1,4]oxazepin-3-yl derivative 1
|
|||
Synonyms |
PMID25435285-Compound-91
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
EISAI R&D MANAGEMENT CO., LTD
|
|||
Structure |
Download2D MOL |
|||
Formula |
C24H26F3N3O2
|
|||
Canonical SMILES |
CCOC1=C(C=CC(=C1)C2=NC(=C3N2CC(OCC3)C)C4=CC(=NC(=C4)C)C)C(F)(F)F
|
|||
InChI |
1S/C24H26F3N3O2/c1-5-31-21-12-17(6-7-19(21)24(25,26)27)23-29-22(18-10-14(2)28-15(3)11-18)20-8-9-32-16(4)13-30(20)23/h6-7,10-12,16H,5,8-9,13H2,1-4H3/t16-/m1/s1
|
|||
InChIKey |
NVGWTIMTJOAYSJ-MRXNPFEDSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Metabotropic glutamate receptor 2 (mGluR2) | Target Info | Antagonist | [1] |
Target's Patent Info | Metabotropic glutamate receptor 2 (mGluR2) | Target's Patent Info | [1] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
Glutamatergic synapse | ||||
Cocaine addiction | ||||
Panther Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | ||||
Ionotropic glutamate receptor pathway | ||||
Metabotropic glutamate receptor group II pathway | ||||
Reactome | G alpha (i) signalling events | |||
Class C/3 (Metabotropic glutamate/pheromone receptors) | ||||
WikiPathways | GPCRs, Class C Metabotropic glutamate, pheromone | |||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | Novel metabotropic glutamate receptor 2/3 antagonists and their therapeutic applications: a patent review (2005 - present).Expert Opin Ther Pat. 2015 Jan;25(1):69-90. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.